| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2023-12-21 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|---|
| Revenue | $15.32M | $23.05M | $12.30M | – | $14.55M | – |
| Cost of Revenue | $7.62M | $12.52M | $6.54M | – | $6.13M | – |
| Gross Profit | $7.70M | $10.53M | $5.76M | – | $8.42M | – |
| Operating Expenses | $14.91M | $14.03M | $12.40M | – | $11.24M | – |
| R&D | $3.08M | $2.80M | $2.73M | – | – | – |
| SG&A | $11.84M | $11.23M | $9.68M | – | $120.00K | $921.35K |
| Operating Income | -$7.22M | -$3.51M | -$6.64M | – | -$1.40M | -$1.02M |
| Interest Expense | – | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | – | $10.00K | – |
| Net Income | $29.32M | -$57.46M | $16.37M | $16.37M | $10.63M | $5.02M |
| EPS (basic) | 0.9000 | -2.3400 | 1.2000 | – | – | – |
| EPS (diluted) | 0.7600 | -2.3400 | 0.8000 | – | – | – |
| Shares (diluted) | $38.68M | $24.59M | $20.39M | $20.39M | $13.39M | – |